Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iHuman (IH) Cash & Current Investments (2020 - 2025)

iHuman has reported Cash & Current Investments over the past 6 years, most recently at $162.3 million for Q4 2025.

  • Quarterly Cash & Current Investments changed 0.25% to $162.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $162.3 million through Dec 2025, changed 0.25% year-over-year, with the annual reading at $162.3 million for FY2025, 1.36% up from the prior year.
  • Cash & Current Investments was $162.3 million for Q4 2025 at iHuman, roughly flat from $162.7 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $168.6 million in Q4 2023 and troughed at $133.8 million in Q4 2021.
  • The 5-year median for Cash & Current Investments is $162.3 million (2025), against an average of $155.0 million.
  • Biggest five-year swings in Cash & Current Investments: grew 14.19% in 2023 and later dropped 3.48% in 2024.
  • Tracing IH's Cash & Current Investments over 5 years: stood at $133.8 million in 2021, then rose by 10.35% to $147.6 million in 2022, then rose by 14.19% to $168.6 million in 2023, then fell by 3.48% to $162.7 million in 2024, then fell by 0.25% to $162.3 million in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $162.3 million, $162.7 million, and $168.6 million for Q4 2025, Q4 2024, and Q4 2023 respectively.